Frits Moolenaar

1.8k total citations
68 papers, 1.3k citations indexed

About

Frits Moolenaar is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Frits Moolenaar has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Pediatrics, Perinatology and Child Health and 15 papers in Oncology. Recurrent topics in Frits Moolenaar's work include Pharmaceutical studies and practices (12 papers), Drug Transport and Resistance Mechanisms (12 papers) and Analytical Methods in Pharmaceuticals (9 papers). Frits Moolenaar is often cited by papers focused on Pharmaceutical studies and practices (12 papers), Drug Transport and Resistance Mechanisms (12 papers) and Analytical Methods in Pharmaceuticals (9 papers). Frits Moolenaar collaborates with scholars based in Netherlands, United States and Pakistan. Frits Moolenaar's co-authors include Dirk K. F. Meijer, Dick de Zeeuw, Jan Visser, T. Huizinga, Leo G. J. de Leede, D. D. Breimer, Albertus G. de Boer, Dirk Meijer, Robbert J. Kok and Marijke Haas and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Controlled Release.

In The Last Decade

Frits Moolenaar

65 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frits Moolenaar Netherlands	21	425	251	194	172	129	68	1.3k
Raymond E. Galinsky United States	21	262 0.6×	164 0.7×	299 1.5×	101 0.6×	56 0.4×	66	1.4k
Ronald D. Schoenwald United States	25	651 1.5×	172 0.7×	233 1.2×	857 5.0×	69 0.5×	74	2.3k
Hitoshi Tada Japan	24	238 0.6×	411 1.6×	379 2.0×	55 0.3×	234 1.8×	96	1.9k
Lewis W. Dittert United States	24	420 1.0×	181 0.7×	368 1.9×	481 2.8×	73 0.6×	81	2.0k
J.J. Vallner United States	15	399 0.9×	85 0.3×	159 0.8×	76 0.4×	55 0.4×	46	941
Yoshiyuki Kagawa Japan	25	596 1.4×	447 1.8×	213 1.1×	154 0.9×	68 0.5×	150	1.9k
Yuji Kurosaki Japan	20	296 0.7×	80 0.3×	164 0.8×	409 2.4×	134 1.0×	96	1.2k
Junko Abe Japan	26	478 1.1×	152 0.6×	302 1.6×	31 0.2×	82 0.6×	81	1.9k
Katsunori Nakamura Japan	24	491 1.2×	99 0.4×	338 1.7×	44 0.3×	141 1.1×	82	1.6k
Jouko Savolainen Finland	19	828 1.9×	147 0.6×	299 1.5×	322 1.9×	114 0.9×	34	2.3k

Countries citing papers authored by Frits Moolenaar

Since Specialization

Citations

This map shows the geographic impact of Frits Moolenaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frits Moolenaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frits Moolenaar more than expected).

Fields of papers citing papers by Frits Moolenaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frits Moolenaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frits Moolenaar. The network helps show where Frits Moolenaar may publish in the future.

Co-authorship network of co-authors of Frits Moolenaar

This figure shows the co-authorship network connecting the top 25 collaborators of Frits Moolenaar. A scholar is included among the top collaborators of Frits Moolenaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frits Moolenaar. Frits Moolenaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prakash, Jai, Martin H. de Borst, M. Lacombe, et al.. (2008). Cell-specific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal Fibrosis. Pharmaceutical Research. 25(10). 2427–2439. 38 indexed citations

Prakash, Jay, Martin H. de Borst, M Lacombe, et al.. (2008). Inhibition of Renal Rho Kinase Attenuates Ischemia/Reperfusion-Induced Injury. Journal of the American Society of Nephrology. 19(11). 2086–2097. 4 indexed citations

Prakash, Jai, Maria Sandovici, Vinay Saluja, et al.. (2006). Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1 H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 319(1). 8–19. 53 indexed citations

Prakash, Jai, Vinay Saluja, Jan Visser, et al.. (2005). Bioanalysis and pharmacokinetics of the p38 MAPkinase inhibitor SB202190 in rats. Journal of Chromatography B. 826(1-2). 220–225. 7 indexed citations

Prakash, Jai, Marijke Haas, Johannes H. Proost, et al.. (2005). RENAL-SELECTIVE DELIVERY AND ANGIOTENSIN-CONVERTING ENZYME INHIBITION BY SUBCUTANEOUSLY ADMINISTERED CAPTOPRIL-LYSOZYME. Drug Metabolism and Disposition. 33(5). 683–688. 20 indexed citations

Haas, Marijke, Frits Moolenaar, Dirk K. F. Meijer, & Dick de Zeeuw. (2002). Specific Drug Delivery to the Kidney. Cardiovascular Drugs and Therapy. 16(6). 489–496. 31 indexed citations

Moolenaar, Frits, et al.. (2002). Targeting of Captopril to the Kidney Reduces Renal Angiotensin-Converting Enzyme Activity without Affecting Systemic Blood Pressure. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1139–1143. 8 indexed citations

Moolenaar, Frits, Willem J. Meijler, Henderik W. Frijlink, J. de Visser, & Johannes H. Proost. (2000). Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain. European Journal of Clinical Pharmacology. 56(3). 219–223. 10 indexed citations

Hooiveld, Guido, Alfred H. Schinkel, Marcel de Haas, et al.. (1999). Transport mechanisms for cationic drugs and proteins in kidney, liver and intestine: implication for drug interactions and cell-specific drug delivery. Nephrology Dialysis Transplantation. 14(suppl 4). 1b–3b. 26 indexed citations

10.

Kok, Robbert J., Marijke Haas, Frits Moolenaar, Dick de Zeeuw, & Dirk Meijer. (1998). Drug Delivery to the Kidneys and the Bladder with the Low Molecular Weight Protein Lysozyme. Renal Failure. 20(2). 211–217. 21 indexed citations

11.

Haas, Marijke, et al.. (1997). Determination of dopaminergic prodrugs by high-performance liquid chromatography followed by post-column ion-pair extraction. Journal of Chromatography B Biomedical Sciences and Applications. 693(2). 484–488. 1 indexed citations

12.

Kok, Robbert J., Jan Visser, Frits Moolenaar, Dick de Zeeuw, & Dirk K. F. Meijer. (1997). Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre- or postcolumn fluorescent labeling. Journal of Chromatography B Biomedical Sciences and Applications. 693(1). 181–189. 48 indexed citations

13.

Haas, Marijke, et al.. (1997). Renal handling of neutral and cationic low-molecular weight proteins during proteinuria. Data Archiving and Networked Services (DANS). 1 indexed citations

14.

Haas, Marijke, et al.. (1997). Urine collection in the freely moving rat: Reliability for measurement of short-term renal effects. Journal of Pharmacological and Toxicological Methods. 38(1). 47–51. 14 indexed citations

15.

Franssen, Eric J. F., Frits Moolenaar, Dick de Zeeuw, & Dirk Meijer. (1993). Low Molecular Weight Proteins as Carriers for Renal Drug Targeting: Naproxen Coupled to Lysozyme via the Spacer L-Lactic Acid. Pharmaceutical Research. 10(7). 963–969. 26 indexed citations

16.

Franssen, Eric J. F., Andries P. Bruins, Frits Moolenaar, et al.. (1992). Low-molecular-weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates. Journal of Medicinal Chemistry. 35(7). 1246–1259. 51 indexed citations

17.

Franssen, Eric J. F., R.G.M. van Amsterdam, Jan Visser, et al.. (1991). Low Molecular Weight Proteins as Carriers for Renal Drug Targeting: Naproxen–Lysozyme. Pharmaceutical Research. 8(10). 1223–1230. 50 indexed citations

18.

Moolenaar, Frits, et al.. (1989). A study on the buffering activity of the human rectum. Pharmacy World & Science. 11(1). 9–12. 6 indexed citations

19.

Moolenaar, Frits, et al.. (1988). Bioavailability of morphine from suppositories. International Journal of Pharmaceutics. 45(1-2). 161–164. 13 indexed citations

20.

Moolenaar, Frits, et al.. (1984). Rectal versus oral absorption of diflunisal in man. International Journal of Pharmaceutics. 19(2). 161–167. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact